Table 2 Masaoka-Koga, TNM staging and histological diagnosis of patients
From: Primary thymus tumors: retrospective case analysis at a reference center in Latin America, 2011–2019
Masaoka-koga | (N = 17) |
|---|---|
age I | 13 (76.4%) |
Stage II | 0 (0%) |
Stage III | 1 (6.2%) |
Stage IV | 3 (17.6%) |
TNM staging system | (N = 17) |
Stage I (T1a,b N0M0) | 13 (76.4%) |
Stage II (T2N0M0) | 1 (6.2%) |
Stage IIIA (T3N0M0) | 0 (0%) |
Stage IIIB (T4N0M0) | 0 (0%) |
Stage IVA (Any T, N1M0/ Any TN0-1M1a) | 0 (0%) |
Stage IVB (Any T, N2M0-M1a/ Any T, Any N, M1b) | 3 (17.6%) |
Histological diagnosis | (N = 18) |
Thymoma | 13 (72.2%) |
Type A | 4 (30.8%) |
Type AB | 2 (15.4%) |
Type B1 | 6 (46.1%) |
Type B2 | 1 (7.7%) |
Thymic neuroendocrine tumors | 2 (11.1%) |
Thymic carcinoma | 1 (5.5%) |
Thymolipoma | 1 (5.5%) |
Thymic cyst | 1 (5.5%) |